Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aida Abu-Baker

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Biochimica Et Biophysica Acta|November 18, 2006
Oculopharyngeal muscular dystrophy: recent advances in the understanding of the molecular pathogenic mechanisms and treatment strategiesAida Abu-Baker, Guy A Rouleau
Human Molecular Genetics|August 29, 2003
Involvement of the ubiquitin-proteasome pathway and molecular chaperones in oculopharyngeal muscular dystrophyAida Abu-Baker, Christiane Messaed, Janet Laganiere, et al.
Traffic (Copenhagen, Denmark)|August 17, 2005
Cytoplasmic targeting of mutant poly(A)-binding protein nuclear 1 suppresses protein aggregation and toxicity in oculopharyngeal muscular dystrophyAida Abu-Baker, Simon Laganiere, Xueping Fan, et al.
Neurology|July 15, 2018
Valproic acid is protective in cellular and worm models of oculopharyngeal muscular dystrophyAida Abu-Baker, Alex Parker, Siriram Ramalingam, et al.
Neurobiology of Disease|April 10, 2007
Soluble expanded PABPN1 promotes cell death in oculopharyngeal muscular dystrophyChristiane Messaed, Patrick A Dion, Aida Abu-Baker, et al.
Human Molecular Genetics|April 10, 2008
Sirtuin inhibition protects from the polyalanine muscular dystrophy protein PABPN1Hélène Catoire, Matthieu Y Pasco, Aida Abu-Baker, et al.
Nucleic Acids Research|November 4, 2015
Automated design of hammerhead ribozymes and validation by targeting the PABPN1 gene transcriptNawwaf Kharma, Luc Varin, Aida Abu-Baker, et al.
Molecular Therapy. Nucleic Acids|March 5, 2019
RNA-Based Therapy Utilizing Oculopharyngeal Muscular Dystrophy Transcript Knockdown and ReplacementAida Abu-Baker, Nawwaf Kharma, Jonathan Perreault, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Biochimica Et Biophysica Acta|November 18, 2006
Oculopharyngeal muscular dystrophy: recent advances in the understanding of the molecular pathogenic mechanisms and treatment strategiesAida Abu-Baker, Guy A Rouleau
Human Molecular Genetics|August 29, 2003
Involvement of the ubiquitin-proteasome pathway and molecular chaperones in oculopharyngeal muscular dystrophyAida Abu-Baker, Christiane Messaed, Janet Laganiere, et al.
Traffic (Copenhagen, Denmark)|August 17, 2005
Cytoplasmic targeting of mutant poly(A)-binding protein nuclear 1 suppresses protein aggregation and toxicity in oculopharyngeal muscular dystrophyAida Abu-Baker, Simon Laganiere, Xueping Fan, et al.
Neurology|July 15, 2018
Valproic acid is protective in cellular and worm models of oculopharyngeal muscular dystrophyAida Abu-Baker, Alex Parker, Siriram Ramalingam, et al.
Neurobiology of Disease|April 10, 2007
Soluble expanded PABPN1 promotes cell death in oculopharyngeal muscular dystrophyChristiane Messaed, Patrick A Dion, Aida Abu-Baker, et al.
Human Molecular Genetics|April 10, 2008
Sirtuin inhibition protects from the polyalanine muscular dystrophy protein PABPN1Hélène Catoire, Matthieu Y Pasco, Aida Abu-Baker, et al.
Nucleic Acids Research|November 4, 2015
Automated design of hammerhead ribozymes and validation by targeting the PABPN1 gene transcriptNawwaf Kharma, Luc Varin, Aida Abu-Baker, et al.
Molecular Therapy. Nucleic Acids|March 5, 2019
RNA-Based Therapy Utilizing Oculopharyngeal Muscular Dystrophy Transcript Knockdown and ReplacementAida Abu-Baker, Nawwaf Kharma, Jonathan Perreault, et al.
Pageof 1